During the past decade, Serena Group Research Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Serena Group Research Institute" #1 collaborator was "Anacapa Technologies Inc" with 1 trials as a collaborator, "MDM Wound Ventures, LLC" with 1 trials as a collaborator and "SerenaGroup, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Serena Group Research Institute" are "Acute Wounds" (2 trials), "Chronic Wounds" (2 trials), "Venous Leg Ulcer" (2 trials), "Wound Leg" (2 trials) and "Wound of Skin" (2 trials). Many other conditions were trialed in "Serena Group Research Institute" in a lesser frequency.

Most popular intervention types in "Serena Group Research Institute" are "Device" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ALLEVYN Non-Adhesive" (1 trials), "AnaSept®" (1 trials), "Aquacel Ag Extra" (1 trials), "EZ Debride®" (1 trials) and "Exufiber" (1 trials). Other intervention names were less common.

The vast majority of trials in "Serena Group Research Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Serena Group Research Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Serena Group Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Serena Group Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".